首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 生物科技 > 生物材料 > 亞太地區的整形外科用生醫材料市場:2011年:人工骨及玻尿酸黏彈性補充
產業/市場分類
生物科技 (1574)
分子標靶治療學 (131)
生技設備 (354)
生物材料 (53)
生物標記 (155)
以基因為基之藥物開發 (202)
再生醫學 (119)
抗體和免疫 (189)
個人化醫學 (51)
基因治療學和RNAi (102)
市場調查報告書

亞太地區的整形外科用生醫材料市場:2011年:人工骨及玻尿酸黏彈性補充

Asia Pacific Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation

出版商 iData Research Inc.
出版日期 2011年07月 商品編碼 203689
內容資訊 英文 358 Pages
價格
US $ 7995 Hard Copy
US $ 8495 PDF by E-mail (Single User License)
US $ 9995 PDF by E-mail (Corporate License)


亞太地區的整形外科用生醫材料市場:2011年:人工骨及玻尿酸黏彈性補充 是由出版商iData Research Inc.在2011年07月所出版的。 這份英文市場調查報告書包含358 Pages 價格從美金7995起跳。

簡介

預計到2017年，亞太地區的整形外科用生醫材料市場，將接近16億美金。而玻尿酸黏彈性補充市場將佔大半以上。雖然市場已趨成熟，但因為亞太地區的高齡化，今後應可預見其持續成長。

本報告以澳洲，日本，韓國，中國為焦點，提供整形外科各生醫材料市場的設備收益，到2017年為止的市場預測，平均銷售價格，詳細的競爭分析，製造商市場佔有率及產品系列等資料，為您概述為以下內容。

第1章 摘要整理

第2章 調查手法

  • 調查範圍
  • 調查手法

第3章 亞太地區的整形外科用生醫材料市場概要

  • 簡介
  • 概要
  • 匯率
  • 市場概要
  • 各分類市場
  • 不同市場區隔趨勢分析
  • 各國家市場
  • 推動市場因素和阻礙因素
  • 競爭分析
  • 合併·收購

第4章 各國家簡介

  • 簡介
  • 日本
  • 中國
  • 韓國
  • 澳洲

第5章 治療數量

  • 概要
    • 適應
    • 不同市場區隔
    • 各國家

第6章 人工骨市場

  • 簡介
  • 日本
    • 市場分析預測
    • 推動市場因素和阻礙因素
    • 競爭分析
  • 中國
    • 市場分析預測
    • 推動市場因素和阻礙因素
    • 競爭分析
  • 韓國
    • 市場分析預測
    • 推動市場因素和阻礙因素
    • 競爭分析
  • 澳洲
    • 市場分析預測
    • 推動市場因素和阻礙因素
    • 競爭分析

第7章 骨骼成型蛋白生長因子治療市場

  • 簡介
  • 澳洲
    • 市場分析
    • 推動市場因素和阻礙因素
    • 競爭分析

第8章 玻尿酸黏彈性補充市場

  • 簡介
    • 單次注射產品
    • 三次循環注射產品
    • 五次循環注射產品
  • 日本
  • 中國
  • 韓國
  • 澳洲

簡稱解說

目錄

Abstract

The Asia-Pacific orthopedic biomaterials market is expected to approach $1.6 billion by 2017. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Asia-Pacific orthopedic biomaterials market.

The Asia-Pacific orthopedic biomaterials report covers the following countries:

  • Japan
  • South Korea
  • Australia
  • China

The segments covered in this report include:

  • autologous bone grafts,
  • bone graft substitutes (BGS; segmented into allografts, demineralized bone matrices and synthetics),
  • hyaluronic acid (HA) viscosupplementation,
  • bone morphogenetic protein (BMP) growth factor therapy
  • autologous chondrocyte implantation (ACI)

The market is approaching maturity, but is expected to continue to grow as a result of the aging Asia-Pacific population. BMP growth factor therapy was the fastest growing segment in 2010, increasing almost 7% over the previous year.

This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1. TOTAL ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET
  • 1.2. HERFINDAHL INDEX COUNTRY PROFILES
  • 1.3. GROWTH TRENDS BY MARKET SEGMENT
  • 1.4. BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS
  • 1.5. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
  • 1.6. BONE MORPHOGENETIC PROTEIN MARKET
  • 1.7. COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA' S 9-STEP METHODOLOGY
    • 2.2.1 Step 1: Project Initiation & Team Selection
    • 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
    • 2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
    • 2.2.4 Step 4: Performing Primary Research
    • 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
    • 2.2.6 Step 6: Market Forecast and Analysis
    • 2.2.7 Step 7: Identify Strategic Opportunities
    • 2.2.8 Step 8: Final Review and Market Release
    • 2.2.9 Step 9: Customer Feedback and Market Monitoring

ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET

  • 3.1. INTRODUCTION
    • 3.1.1. Growth Factors
    • 3.1.2. Bone Graft Substitutes
    • 3.1.3. Hyaluronic Acid Viscosupplementation
  • 3.2. CURRENCY EXCHANGE RATES
  • 3.3. MARKET OVERVIEW
  • 3.4. MARKET BY SEGMENT
  • 3.5. TREND ANALYSIS BY SEGMENT
  • 3.6. MARKET BY COUNTRY
    • 3.6.1. Total Market
    • 3.6.2. Japan
    • 3.6.3. China
    • 3.6.4. South Korea
    • 3.6.5. Australia
  • 3.7. MARKET DRIVERS AND LIMITERS
    • 3.7.1. Market Drivers
    • 3.7.2. Market Limiters
  • 3.8. COMPETITIVE ANALYSIS
    • 3.8.1. Herfindahl Index
  • 3.9. MERGERS AND ACQUISITIONS

COUNTRY PROFILES

  • 4.1. INTRODUCTION
    • 4.1.1. Population
    • 4.1.2. GDP per Capita
    • 4.1.3. Price Index
  • 4.2. JAPAN
  • 4.3. CHINA
  • 4.4. SOUTH KOREA
  • 4.5. AUSTRALIA

PROCEDURE NUMBERS

  • 5.1. OVERVIEW
    • 5.1.1. Total Orthopedic Bone Graft Substitute Procedures by Indication
    • 5.1.2. Total Orthopedic Bone Graft Substitute Procedures by Segment
    • 5.1.3. Total Orthopedic Bone Graft Substitute Procedures by Country

BONE GRAFT SUBSTITUTE MARKET

  • 6.1. INTRODUCTION
    • 6.1.1. Volumes Represented per Procedure
  • 6.2. JAPAN
    • 6.2.1. Market Analysis and Forecast
      • 6.2.1.1. Volumes Represented per Procedure
      • 6.2.1.2. Total Synthetic Market
      • 6.2.1.3. Synthetic Spine Market
      • 6.2.1.4. Synthetic Cervical Spine Market
      • 6.2.1.5. Synthetic Thoracolumbar Spine Market
      • 6.2.1.6. Synthetic Trauma and Reconstruction Market
      • 6.2.1.7. Synthetic Craniomaxillofacial Market
    • 6.2.2. Market Drivers and Limiters
      • 6.2.2.1. Market Drivers
      • 6.2.2.2. Market Limiters
    • 6.2.3. Competitive Analysis
  • 6.3. CHINA
    • 6.3.1. Overview
    • 6.3.2. Market Analysis and Forecast
      • 6.3.2.1. Total Allograft Market
      • 6.3.2.2. Allograft Spine Market
      • 6.3.2.3. Allograft Cervical Spine Market
      • 6.3.2.4. Allograft Thoracolumbar Spine Market
      • 6.3.2.5. Allograft Trauma & Reconstruction Market
      • 6.3.2.6. Allograft Craniomaxillofacial Market
      • 6.3.2.7. Total Synthetic Market
      • 6.3.2.8. Synthetic Spine Market
      • 6.3.2.9. Synthetic Cervical Spine Market
      • 6.3.2.10. Synthetic Thoracolumbar Spine Market
      • 6.3.2.11. Synthetic Trauma & Reconstruction Market
      • 6.3.2.12. Synthetic Craniomaxillofacial Market
      • 6.3.2.13. Total DBM Market
      • 6.3.2.14. DBM Spine Market
      • 6.3.2.15. DBM Cervical Spine Market
      • 6.3.2.16. DBM Thoracolumbar Spine Market
      • 6.3.2.17. DBM Trauma & Reconstruction Market
      • 6.3.2.18. DBM Craniomaxillofacial Market
    • 6.3.3. Market Drivers and Limiters
      • 6.3.3.1. Market Drivers
      • 6.3.3.2. Market Limiters
    • 6.3.4. Competitive Analysis
  • 6.4. SOUTH KOREA
    • 6.4.1. Overview
    • 6.4.2. Market Analysis and Forecast
      • 6.4.2.1. Total Allograft Market
      • 6.4.2.2. Allograft Spine Market
      • 6.4.2.3. Allograft Cervical Spine Market
      • 6.4.2.4. Allograft Thoracolumbar Spine Market
      • 6.4.2.5. Allograft Trauma & Reconstruction Market
      • 6.4.2.6. Allograft Craniomaxillofacial Market
      • 6.4.2.7. Total Synthetic Market
      • 6.4.2.8. Synthetic Spine Market
      • 6.4.2.9. Synthetic Cervical Spine Market
      • 6.4.2.10. Synthetic Thoracolumbar Spine Market
      • 6.4.2.11. Synthetic Trauma & Reconstruction Market
      • 6.4.2.12. Synthetic Craniomaxillofacial Market
      • 6.4.2.13. Total Demineralized Bone Matrix Market
      • 6.4.2.14. DBM Spine Market
      • 6.4.2.15. DBM Cervical Spine Market
      • 6.4.2.16. DBM Thoracolumbar Spine Market
      • 6.4.2.17. DBM Trauma & Reconstruction Market
      • 6.4.2.18. DBM Craniomaxillofacial Market
    • 6.4.3. Market Drivers and Limiters
      • 6.4.3.1. Market Drivers
      • 6.4.3.2. Market Limiters
    • 6.4.4. Competitive Analysis
  • 6.5. AUSTRALIA
    • 6.5.1. Overview
    • 6.5.2. Market Analysis and Forecast
      • 6.5.2.1. Total Allograft Market
      • 6.5.2.2. Allograft Spine Market
      • 6.5.2.3. Allograft Cervical Spine Market
      • 6.5.2.4. Allograft Thoracolumbar Spine Market
      • 6.5.2.5. Allograft Trauma & Reconstruction Market
      • 6.5.2.6. Allograft Craniomaxillofacial Market
      • 6.5.2.7. Total Synthetic Market
      • 6.5.2.8. Synthetic Spine Market
      • 6.5.2.9. Synthetic Cervical Spine Market
      • 6.5.2.10. Synthetic Thoracolumbar Spine Market
      • 6.5.2.11. Synthetic Trauma & Reconstruction Market
      • 6.5.2.12. Synthetic Craniomaxillofacial Market
    • 6.5.3. Market Drivers and Limiters
      • 6.5.3.1. Market Drivers
      • 6.5.3.2. Market Limiters
    • 6.5.4. Competitive Analysis

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

  • 7.1. INTRODUCTION
    • 7.1.1. Overview
    • 7.1.2. Potential Complications
  • 7.2. AUSTRALIA
    • 7.2.1. Market Analysis and Forecast
      • 7.2.1.1. Total BMP Market
    • 7.2.2. Market Drivers and Limiters
      • 7.2.2.1. Market Drivers
      • 7.2.2.2. Market Limiters
    • 7.2.3. Competitive Analysis

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 8.1. INTRODUCTION
    • 8.1.1.1. Single-Injection Products
    • 8.1.1.2. Three-Injection Cycle Products
    • 8.1.1.3. Five-Injection Cycle Products
  • 8.2. JAPAN
    • 8.2.1. Market Analysis and Forecast
      • 8.2.1.1. Total Hyaluronic Acid Viscosupplementation Market
    • 8.2.2. Market Drivers and Limiters
      • 8.2.2.1. Market Drivers
      • 8.2.2.2. Market Limiters
    • 8.2.3. Competitive Analysis
  • 8.3. CHINA
    • 8.3.1. Market Analysis and Forecast
      • 8.3.1.1. Total Hyaluronic Acid Viscosupplementation Market
    • 8.3.2. Market Analysis and Forecast
      • 8.3.2.1. Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market
      • 8.3.2.2. Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market
    • 8.3.3. Market Drivers and Limiters
      • 8.3.3.1. Market Drivers
      • 8.3.3.2. Market Limiters
    • 8.3.4. Competitive Analysis
  • 8.4. SOUTH KOREA
    • 8.4.1. Overview
    • 8.4.2. Market Analysis and Forecast
      • 8.4.2.1. Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market
      • 8.4.2.2. Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market
    • 8.4.3. Market Drivers and Limiters
      • 8.4.3.1. Market Drivers
      • 8.4.3.2. Market Limiters
    • 8.4.4. Competitive Analysis
  • 8.5. AUSTRALIA
    • 8.5.1. Market Analysis and Forecast
    • 8.5.2. Market Drivers and Limiters
      • 8.5.2.1. Market Drivers
      • 8.5.2.2. Market Limiters
    • 8.5.3. Competitive Analysis

ABBREVIATIONS

APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BY WEIGHT

APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

APPENDIX 3: EMERGING MARKETS

  • 12.1. BONE MORPHOGENETIC PROTEIN MARKET
  • 12.2. AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

LIST OF FIGURES

EXECUTIVE SUMMARY

  • Figure 1-1: Total Orthopedic Biomaterials Market, Asia-Pacific, 2010 (US$M)
  • Figure 1-2: Herfindahl Index by Country, Asia-Pacific, 2010
  • Figure 1-3: Growth Trends, Orthopedic Biomaterials Market, Asia-Pacific, 2007 - 2017
  • Figure 1-4: Procedure Numbers, Bone Graft Substitute Market, Asia-Pacific, 2007 - 2017
  • Figure 1-5: Growth Rates, Hyaluronic Acid Viscosupplementation Market, Asia-Pacific, 2007 - 2017
  • Figure 1-6: Bone Morphogenetic Protein Market, Australia, 2007 - 2017 (US$M)
  • Figure 1-7: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific, 2010

RESEARCH METHODOLOGY

ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET

  • Figure 3-1: Exchange Rate for Currencies, 2010
  • Figure 3-2: Orthopedic Biomaterials Market, Asia-Pacific, 2007 - 2017
  • Figure 3-3: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2007 - 2017 (US$M)
  • Figure 3-4: Growth Rates by Segment, Orthopedic Biomaterials Market, Asia-Pacific, 2007 - 2017
  • Figure 3-5: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2007 - 2017 (US$M)
  • Figure 3-6: Orthopedic Biomaterials Market by Segment, Japan, 2007 - 2017 (US$M)
  • Figure 3-7: Orthopedic Biomaterials Market by Segment, Japan, 2007 - 2017 (JP¥M)
  • Figure 3-8: Orthopedic Biomaterials Market by Segment, China, 2007 - 2017 (US$M)
  • Figure 3-9: Orthopedic Biomaterials Market by Segment, China, 2007 - 2017 (CNY M)
  • Figure 3-10: Orthopedic Biomaterials Market by Segment, South Korea, 2007 - 2017 (US$M)
  • Figure 3-11: Orthopedic Biomaterials Market by Segment, South Korea, 2007 - 2017 (KR₩ M)
  • Figure 3-12: Orthopedic Biomaterials Market by Segment, Australia, 2007 - 2017 (US$M)
  • Figure 3-13: Orthopedic Biomaterials Market by Segment, Australia, 2007 - 2017 (AU$M)
  • Figure 3-14: Drivers and Limiters, Orthopedic Biomaterials Market, Asia-Pacific, 2010
  • Figure 3-15: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific, 2010 (1 of 2)
  • Figure 3-16: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific, 2010 (2 of 2)
  • Figure 3-17: H-Index, Orthopedic Biomaterials Market, Asia-Pacific, 2010

COUNTRY PROFILES

  • Figure 4-1: Country Indicators, Asia-Pacific, 2010

PROCEDURE NUMBERS

  • Figure 5-1: Total Bone Graft Substitute Procedures by Indication, Asia-Pacific, 2007 - 2017
  • Figure 5-2: Total Orthopedic Bone Graft Substitute Procedures by Segment, Asia-Pacific, 2007 - 2017
  • Figure 5-3: Total Orthopedic Bone Graft Substitute Procedures by Country, Asia-Pacific, 2007 - 2017

BONE GRAFT SUBSTITUTE MARKET

  • Figure 6-1: Total Synthetic Market, Japan, 2007 - 2017 (US$)
  • Figure 6-2: Total Synthetic Market, Japan, 2007 - 2017 (JP¥)
  • Figure 6-3: Synthetic Total Spine Market, Japan, 2007 - 2017 (US$)
  • Figure 6-4: Synthetic Total Spine Market, Japan, 2007 - 2017 (JP¥)
  • Figure 6-5: Synthetic Cervical Spine Market, Japan, 2007 - 2017 (US$)
  • Figure 6-6: Synthetic Cervical Spine Market, Japan, 2007 - 2017 (JP¥)
  • Figure 6-7: Synthetic Thoracolumbar Spine Market, Japan, 2007 - 2017 (US$)
  • Figure 6-8: Synthetic Thoracolumbar Spine Market, Japan, 2007 - 2017 (JP¥)
  • Figure 6-9: Synthetic Trauma & Reconstruction Market, Japan, 2007 - 2017 (US$)
  • Figure 6-10: Synthetic Trauma & Reconstruction Market, Japan, 2007 - 2017 (JP¥)
  • Figure 6-11: Synthetic Craniomaxillofacial Market, Japan, 2007 - 2017 (US$)
  • Figure 6-12: Synthetic Craniomaxillofacial Market, Japan, 2007 - 2017 (JP¥)
  • Figure 6-13: Drivers and Limiters, Bone Graft Substitute Market, Japan, 2010
  • Figure 6-14: Leading Competitors, Bone Graft Substitute Market, Japan, 2010
  • Figure 6-15: Bone Graft Substitute Market by Segment, China, 2007 - 2017 (US$M)
  • Figure 6-16: Bone Graft Substitute Market by Segment, China, 2007 - 2017 (CNY M)
  • Figure 6-17: Total Allograft Market, China, 2007 - 2017 (US$)
  • Figure 6-18: Total Allograft Market, China, 2007 - 2017 (CNY)
  • Figure 6-19: Allograft Total Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-20: Allograft Total Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-21: Allograft Cervical Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-22: Allograft Cervical Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-23: Allograft Thoracolumbar Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-24: Allograft Thoracolumbar Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-25: Allograft Trauma & Reconstruction Market, China, 2007 - 2017 (US$)
  • Figure 6-26: Allograft Trauma & Reconstruction Market, China, 2007 - 2017 (CNY)
  • Figure 6-27: Allograft Craniomaxillofacial Market, China, 2007 - 2017 (US$)
  • Figure 6-28: Allograft Craniomaxillofacial Market, China, 2007 - 2017 (CNY)
  • Figure 6-29: Total Synthetic Market, China, 2007 - 2017 (US$)
  • Figure 6-30: Total Synthetic Market, China, 2007 - 2017 (CNY)
  • Figure 6-31: Synthetic Total Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-32: Synthetic Total Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-33: Synthetic Cervical Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-34: Synthetic Cervical Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-35: Synthetic Thoracolumbar Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-36: Synthetic Thoracolumbar Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-37: Synthetic Trauma & Reconstruction Market, China, 2007 - 2017 (US$)
  • Figure 6-38: Synthetic Trauma & Reconstruction Market, China, 2007 - 2017 (CNY)
  • Figure 6-39: Synthetic Craniomaxillofacial Market, China, 2007 - 2017 (US$)
  • Figure 6-40: Synthetic Craniomaxillofacial Market, China, 2007 - 2017 (CNY)
  • Figure 6-41: Total DBM Market, China, 2007 - 2017 (US$)
  • Figure 6-42: Total DBM Market, China, 2007 - 2017 (CNY)
  • Figure 6-43: DBM Total Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-44: DBM Total Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-45: DBM Cervical Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-46: DBM Cervical Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-47: DBM Thoracolumbar Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-48: DBM Thoracolumbar Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-49: DBM Trauma & Reconstruction Market, China, 2007 - 2017 (US$)
  • Figure 6-50: DBM Trauma & Reconstruction Market, China, 2007 - 2017 (CNY)
  • Figure 6-51: DBM Craniomaxillofacial Market, China, 2007 - 2017 (US$)
  • Figure 6-52: DBM Craniomaxillofacial Market, China, 2007 - 2017 (CNY)
  • Figure 6-53: Drivers and Limiters, Bone Graft Substitute Market, China, 2010
  • Figure 6-54: Leading Competitors, Bone Graft Substitute Market, China, 2010
  • Figure 6-55: Bone Graft Substitute Market by Segment, South Korea, 2007 - 2017 (US$M)
  • Figure 6-56: Bone Graft Substitute Market by Segment, South Korea, 2007 - 2017 (KR₩ M)
  • Figure 6-57: Total Allograft Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-58: Total Allograft Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-59: Allograft Total Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-60: Allograft Total Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-61: Allograft Cervical Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-62: Allograft Cervical Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-63: Allograft Thoracolumbar Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-64: Allograft Thoracolumbar Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-65: Allograft Trauma & Reconstruction Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-66: Allograft Trauma & Reconstruction Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-67: Allograft Craniomaxillofacial Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-68: Allograft Craniomaxillofacial Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-69: Total Synthetic Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-70: Total Synthetic Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-71: Synthetic Total Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-72: Synthetic Total Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-73: Synthetic Cervical Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-74: Synthetic Cervical Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-75: Synthetic Thoracolumbar Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-76: Synthetic Thoracolumbar Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-77: Synthetic Trauma & Reconstruction Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-78: Synthetic Trauma & Reconstruction Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-79: Synthetic Craniomaxillofacial Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-80: Synthetic Craniomaxillofacial Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-81: Total DBM Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-82: Total DBM Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-83: DBM Total Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-84: DBM Total Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-85: DBM Cervical Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-86: DBM Cervical Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-87: DBM Thoracolumbar Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-88: DBM Thoracolumbar Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-89: DBM Trauma & Reconstruction Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-90: DBM Trauma & Reconstruction Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-91: DBM Craniomaxillofacial Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-92: DBM Craniomaxillofacial Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-93: Drivers and Limiters, Bone Graft Substitute Market, South Korea, 2010
  • Figure 6-94: Leading Competitors, Bone Graft Substitute Market, South Korea, 2010
  • Figure 6-95: Bone Graft Substitute Market by Segment, Australia, 2007 - 2017 (US$M)
  • Figure 6-96: Bone Graft Substitute Market by Segment, Australia, 2007 - 2017 (AU$M)
  • Figure 6-97: Total Allograft Market, Australia, 2007 - 2017 (US$)
  • Figure 6-98: Total Allograft Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-99: Allograft Total Spine Market, Australia, 2007 - 2017 (US$)
  • Figure 6-100: Allograft Total Spine Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-101: Allograft Cervical Spine Market, Australia, 2007 - 2017 (US$)
  • Figure 6-102: Allograft Cervical Spine Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-103: Allograft Thoracolumbar Spine Market, Australia, 2007 - 2017 (US$)
  • Figure 6-104: Allograft Thoracolumbar Spine Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-105: Allograft Trauma & Reconstruction Market, Australia, 2007 - 2017 (US$)
  • Figure 6-106: Allograft Trauma & Reconstruction Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-107: Allograft Craniomaxillofacial Market, Australia, 2007 - 2017 (US$)
  • Figure 6-108: Allograft Craniomaxillofacial Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-109: Total Synthetic Market, Australia, 2007 - 2017 (US$)
  • Figure 6-110: Total Synthetic Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-111: Synthetic Total Spine Market, Australia, 2007 - 2017 (US$)
  • Figure 6-112: Synthetic Total Spine Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-113: Synthetic Cervical Spine Market, Australia, 2007 - 2017 (US$)
  • Figure 6-114: Synthetic Cervical Spine Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-115: Synthetic Thoracolumbar Spine Market, Australia, 2007 - 2017 (US$)
  • Figure 6-116: Synthetic Thoracolumbar Spine Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-117: Synthetic Trauma & Reconstruction Market, Australia, 2007 - 2017 (US$)
  • Figure 6-118: Synthetic Trauma & Reconstruction Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-119: Synthetic Craniomaxillofacial Market, Australia, 2007 - 2017 (US$)
  • Figure 6-120: Synthetic Craniomaxillofacial Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-121: Drivers and Limiters, Bone Graft Substitute Market, Australia, 2010
  • Figure 6-122: Leading Competitors, Bone Graft Substitute Market, Australia, 2010
  • Figure 6-123: Leading Competitors, Bone Graft Substitute Market, Australia, 2010

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

  • Figure 7-1: Bone Morphogenetic Market, Australia, 2007 - 2017 (US$)
  • Figure 7-2: Bone Morphogenetic Market, Australia, 2007 - 2017 (AU$)
  • Figure 7-3: Drivers and Limiters, Bone Morphogenetic Protein Market, Australia, 2010
  • Figure 7-4: Leading Competitors, Bone Morphogenetic Protein Market, Australia, 2010

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Figure 8-1: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 - 2017 (US$)
  • Figure 8-2: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 - 2017 (JP¥)
  • Figure 8-3: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Japan, 2010
  • Figure 8-4: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Japan, 2010
  • Figure 8-5: Total Hyaluronic Acid Viscosupplementation Market,
  • Figure 8-6: Total Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (CNY M)
  • Figure 8-7: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (US$)
  • Figure 8-8: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (CNY)
  • Figure 8-9: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (US$)
  • Figure 8-10: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (CNY)
  • Figure 8-11: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, China, 2010
  • Figure 8-12: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2010
  • Figure 8-13: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (US$M)
  • Figure 8-14: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (KR₩ M)
  • Figure 8-15: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (US$)
  • Figure 8-16: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 8-17: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (US$)
  • Figure 8-18: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 8-19: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, South Korea, 2010
  • Figure 8-20: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, South Korea, 2010
  • Figure 8-21: Hyaluronic Acid Viscosupplementation Market, Australia, 2007 - 2017 (US$)
  • Figure 8-22: Hyaluronic Acid Viscosupplementation Market, Australia, 2007 - 2017 (AU$)
  • Figure 8-23: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Australia, 2010
  • Figure 8-24: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Australia, 2010

ABBREVIATIONS

APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BY WEIGHT

  • Figure 10-1: Total Synthetic Market, Japan, 2007 - 2017 (US$)
  • Figure 10-2: Total Synthetic Market, Japan, 2007 - 2017 (JP¥)
  • Figure 10-3: Synthetic Total Spine Market, Japan, 2007 - 2017 (US$)
  • Figure 10-4: Synthetic Total Spine Market, Japan, 2007 - 2017 (JP¥)
  • Figure 10-5: Synthetic Cervical Spine Market, Japan, 2007 - 2017 (US$)
  • Figure 10-6: Synthetic Cervical Spine Market, Japan, 2007 - 2017 (JP¥)
  • Figure 10-7: Synthetic Thoracolumbar Spine Market, Japan, 2007 - 2017 (US$)
  • Figure 10-8: Synthetic Thoracolumbar Spine Market, Japan, 2007 - 2017 (JP¥)
  • Figure 10-9: Synthetic Trauma & Reconstruction Market, Japan, 2007 - 2017 (US$)
  • Figure 10-10: Synthetic Trauma & Reconstruction Market, Japan, 2007 - 2017 (JP¥)
  • Figure 10-11: Synthetic Craniomaxillofacial Market, Japan, 2007 - 2017 (US$)
  • Figure 10-12: Synthetic Craniomaxillofacial Market, Japan, 2007 - 2017 (JP¥)

APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Figure 11-1: Exchange Rate for Currencies, 2010
  • Figure 11-2: Hyaluronic Acid Viscosupplementation Market, Taiwan, 2007 - 2017 (US$)
  • Figure 11-3: Hyaluronic Acid Viscosupplementation Market, Taiwan, 2007 - 2017 (TW$)

APPENDIX 3: EMERGING MARKETS

LIST OF CHARTS

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET

  • Chart 3-1: Orthopedic Biomaterials Market, Asia-Pacific, 2007 - 2017 (US$M)
  • Chart 3-2: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2007 - 2017 (US$M)
  • Chart 3-3: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2010
  • Chart 3-4: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2017
  • Chart 3-5: Growth Rates by Segment, Orthopedic Biomaterials Market, Asia-Pacific, 2007 - 2017
  • Chart 3-6: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2007 - 2017 (US$M)
  • Chart 3-7: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2010
  • Chart 3-8: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2017
  • Chart 3-9: Orthopedic Biomaterials Market by Segment, Japan, 2007 - 2017 (US$M)
  • Chart 3-10: Orthopedic Biomaterials Market by Segment, Japan, 2010
  • Chart 3-11: Orthopedic Biomaterials Market by Segment, Japan, 2017
  • Chart 3-12: Orthopedic Biomaterials Market by Segment, China, 2007 - 2017 (US$M)
  • Chart 3-13: Orthopedic Biomaterials Market by Segment, China, 2010
  • Chart 3-14: Orthopedic Biomaterials Market by Segment, China, 2017
  • Chart 3-15: Orthopedic Biomaterials Market by Segment, South Korea, 2007 - 2017 (US$M)
  • Chart 3-16: Orthopedic Biomaterials Market by Segment, South Korea, 2010
  • Chart 3-17: Orthopedic Biomaterials Market by Segment, South Korea, 2017
  • Chart 3-18: Orthopedic Biomaterials Market by Segment, Australia, 2007 - 2017 (US$M)
  • Chart 3-19: Orthopedic Biomaterials Market by Segment, Australia, 2010
  • Chart 3-20: Orthopedic Biomaterials Market by Segment, Australia, 2017
  • Chart 3-21: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific, 2010
  • Chart 3-22: H-Index, Orthopedic Biomaterials Market, Asia-Pacific, 2010

COUNTRY PROFILES

  • Chart 4-1: Country Profile, Japan, 2010
  • Chart 4-2: Country Profile, China, 2010
  • Chart 4-3: Country Profile, South Korea, 2010
  • Chart 4-4: Country Profile, Australia, 2010

PROCEDURE NUMBERS

  • Chart 5-1: Orthopedic Bone Graft Substitute Procedures by Indication, Asia-Pacific, 2010
  • Chart 5-2: Orthopedic Bone Graft Substitute Procedures by Indication, Asia-Pacific, 2017
  • Chart 5-3: Total Orthopedic Bone Graft Substitute Procedures by Segment, Asia-Pacific, 2010
  • Chart 5-4: Total Orthopedic Bone Graft Substitute Procedures by Segment, Asia-Pacific, 2017
  • Chart 5-5: Total Orthopedic Bone Graft Substitute Procedures by Country, Asia-Pacific, 2010
  • Chart 5-6: Total Orthopedic Bone Graft Substitute Procedures by Country, Asia-Pacific, 2017

BONE GRAFT SUBSTITUTE MARKET

  • Chart 6-1: Total Synthetic Market, Japan, 2007 - 2017 (US$M)
  • Chart 6-2: Synthetic Total Spine Market, Japan, 2007 - 2017 (US$M)
  • Chart 6-3: Synthetic Cervical Spine Market, Japan, 2007 - 2017 (US$M)
  • Chart 6-4: Synthetic Thoracolumbar Spine Market, Japan, 2007 - 2017 (US$M)
  • Chart 6-5: Synthetic Trauma & Reconstruction Market, Japan, 2007 - 2017 (US$M)
  • Chart 6-6: Synthetic Craniomaxillofacial Market, Japan, 2007 - 2017 (US$M)
  • Chart 6-7: Leading Competitors, Bone Graft Substitute Market, Japan, 2010
  • Chart 6-8: Bone Graft Substitute Market by Segment, China, 2007 - 2017 (US$M)
  • Chart 6-9: Bone Graft Substitute Market by Segment, China, 2010
  • Chart 6-10: Bone Graft Substitute Market by Segment, China, 2017
  • Chart 6-11: Total Allograft Market, China, 2007 - 2017 (US$M)
  • Chart 6-12: Allograft Total Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-13: Allograft Cervical Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-14: Allograft Thoracolumbar Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-15: Allograft Trauma & Reconstruction Market, China, 2007 - 2017 (US$M)
  • Chart 6-16: Allograft Craniomaxillofacial Market, China, 2007 - 2017 (US$M)
  • Chart 6-17: Total Synthetic Market, China, 2007 - 2017 (US$M)
  • Chart 6-18: Synthetic Total Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-19: Synthetic Cervical Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-20: Synthetic Thoracolumbar Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-21: Synthetic Trauma & Reconstruction Market, China, 2007 - 2017 (US$M)
  • Chart 6-22: Synthetic Craniomaxillofacial Market, China, 2007 - 2017 (US$M)
  • Chart 6-23: Total DBM Market, China, 2007 - 2017 (US$M)
  • Chart 6-24: DBM Total Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-25: DBM Cervical Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-26: DBM Thoracolumbar Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-27: DBM Trauma & Reconstruction Market, China, 2007 - 2017 (US$M)
  • Chart 6-28: DBM Craniomaxillofacial Market, China, 2007 - 2017 (US$M)
  • Chart 6-29: Leading Competitors, Bone Graft Substitute Market, China, 2010
  • Chart 6-30: Bone Graft Substitute Market by Segment, South Korea, 2007 - 2017 (US$M)
  • Chart 6-31: Bone Graft Substitute Market by Segment, South Korea, 2010
  • Chart 6-32: Bone Graft Substitute Market by Segment, South Korea, 2017
  • Chart 6-33: Total Allograft Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-34: Allograft Total Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-35: Allograft Cervical Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-36: Allograft Thoracolumbar Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-37: Allograft Trauma & Reconstruction Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-38: Allograft Craniomaxillofacial Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-39: Total Synthetic Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-40: Synthetic Total Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-41: Synthetic Cervical Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-42: Synthetic Thoracolumbar Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-43: Synthetic Trauma & Reconstruction Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-44: Synthetic Craniomaxillofacial Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-45: Total DBM Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-46: DBM Total Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-47: DBM Cervical Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-48: DBM Thoracolumbar Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-49: DBM Trauma & Reconstruction Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-50: DBM Craniomaxillofacial Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-51: Leading Competitors, Bone Graft Substitute Market, South Korea, 2010
  • Chart 6-52: Bone Graft Substitute Market by Segment, Australia, 2007 - 2017 (US$M)
  • Chart 6-53:Bone Graft Substitute Market by Segment, Australia, 2010
  • Chart 6-54: Bone Graft Substitute Market by Segment, Australia, 2017
  • Chart 6-55: Total Allograft Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-56: Allograft Total Spine Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-57: Allograft Cervical Spine Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-58: Allograft Thoracolumbar Spine Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-59: Allograft Trauma & Reconstruction Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-60: Allograft Craniomaxillofacial Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-61: Total Synthetic Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-62: Synthetic Total Spine Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-63: Synthetic Cervical Spine Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-64: Synthetic Thoracolumbar Spine Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-65: Synthetic Trauma & Reconstruction Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-66: Synthetic Craniomaxillofacial Market, Australia, 2007 - 2017 (US$M)

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

  • Chart 7-1: Bone Morphogenetic Market, Australia, 2007 - 2017 (US$M)
  • Chart 7-2: Leading Competitors, Bone Morphogenetic Protein Market, Australia, 2010

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Chart 8-1: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 - 2017 (US$M)
  • Chart 8-2: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Japan, 2010
  • Chart 8-3: Total Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (US$M)
  • Chart 8-4: Total Hyaluronic Acid Viscosupplementation Market, China, 2010
  • Chart 8-5: Total Hyaluronic Acid Viscosupplementation Market, China, 2017
  • Chart 8-6: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (US$M)
  • Chart 8-7: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (US$M)
  • Chart 8-8: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2010
  • Chart 8-9: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (US$M)
  • Chart 8-10: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2010
  • Chart 8-11: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2017
  • Chart 8-12: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (US$M)
  • Chart 8-13: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (US$M)
  • Chart 8-14: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, South Korea, 2010
  • Chart 8-15: Hyaluronic Acid Viscosupplementation Market, Australia, 2010 - 2017 (US$M)
  • Chart 8-16: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Australia, 2010

ABBREVIATIONS

APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BY WEIGHT

APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Chart 11-1: Hyaluronic Acid Viscosupplementation Market, Taiwan, 2007 - 2017 (US$M)

APPENDIX 3: EMERGING MARKETS

Press Release

生化學工業、HOYA、Olympus領導據稱是930億日元市場的亞太地區骨移植及透明質酸市場

2011年08月01日

利用脫鹽骨基質的處理手術呈2位數成長

Global Information, Inc.已開始銷售加拿大調查公司iData Research Inc.所發行的報告書「Asia Pacific Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (亞太地區的整形外科用生醫材料市場:2011年:人工骨及玻尿酸黏彈性補充)」

依據該報告，亞太地區（日本、韓國、中國、台灣、澳洲）的整形外科用生物材料市場，預計於2017年達到1400億日元（16億美元）。

此成長獲得在更多適應的骨代用材料治療效驗中的認可。且佔此市場大部分的透明質酸粘性彈性補給區塊，因Genzyme的Synvisc®登場，預料將在日本大幅成長。據此，使用以往非類固醇消炎藥物（Non-Steroidal Anti-Inflammatory Drugs：NSAIDs）的治療作為替代治療法，提高大眾的注目，且擴大到腰痛和肩膀痛、關節風濕的治療。

是IData分析經理的Douglas Fung博士敘述：「2010年的總體市場，因韓國開始償還政策導致價格下跌。」「然預測到2011年底之前，韓國在骨形成蛋白質(BMP)增殖因子療法領域，出現強有力的成長。Korea Bone Bank和Cowell Medical等最近正在摸索如何獲得法規當局的認可。」。

該報告敘述，在透明質酸粘性補給市場，生化學工業是亞太地區的領袖企業，BGS市場由領導日本人工骨市場的HOYA和Olympus Terumo Biomaterials Corp.支配。此外，在韓國和中國，Korea Bone Bank和Shanxi Tissue Bank顯示其存在。
Back to Top